Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-503-3 | CAS number: 68441-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The substance showed moderate acute oral toxicity in male rats (LD50 = 1337 mg/kg bw). Regarding inhalation exposure, the 4-hour LC50 is above 5.47 g/m3 for male and female rats.
Key value for chemical safety assessment
Additional information
An acute oral toxicity study and an acute inhalation toxicity study are available for assessment. Both studies were performed with Polyol IXOL B251. Polyol IXOL B251 is a mixture consisting of 93-94% Polyol IXOL B350 and 6-7% triethyl phosphate (CAS number: 78-40-0). Based on the available data on triethyl phosphate as summarised in the OECD SIDS of that substance, it is not expected that 6-7% triethyl phosphate as present in Polyol IXOL B251 changes the toxicity profile significantly, i.e., the toxicity profiles of Polyol IXOL B350 and Polyol IXOL B251 are considered similar.
Oral route
The acute oral toxicity of Polyol IXOL B251 was investigated in a GLP compliant study using a protocol similar to OECD guideline 401 (Duphar B.V., 1985a). Single doses of B251 in 1%-tragacanth were given by stomach tube to groups of five male fasted rats. The doses were 625, 1250, 2500 and 5000 mg/kg bw. The animals were weighed one day before and at 2, 7 and 14 days after dosing. Any toxic sign occurringduring the 14-day observation period was recorded. Gross post-mortem examination was done on dead animals and on the survivors at the end of the 14-day observation period.
At 625 mg/kg bw, no mortalities were observed; at 1250 mg/kg bw, 3/5 animals died; at 2500 mg/kg bw: 4/5 animals died and 5000 mg/kg bw: 5/5 animals died. The LD50 was 1337 mg/kg bw. There was a dose-related weight loss in the first days after dosing. Thereafter there was a recovery. The signs were mainly indicative of an effect on the autonomic nervous system (hypothermia, ptosis, diminished respiratory rate, pilo-erection, lacrimation), on the central nervous system (apathy, twitches, diminished alertness and startle response, positional passivity, decreased grooming), on motor coordination (loss of righting reflex, diminished locomotor activity, abnormal gait) and on muscle tone (diminished body tone and limb tone). Autopsy of the rats that died as a result of treatment revealed effects on the gastro-intestinal tract (irritation), kidneys (pale), liver (pale), lymph nodes (congested) and lungs (red spots).
Inhalation route
The acute inhalation toxicity of Polyol IXOL B251 was investigated in a GLP compliant, OECD guideline 403 study in rats (TNO, 2010a). The actual concentration during exposure was 5.47 ± 0.05 g/m3. Body weight was measured just before exposure and weekly thereafter. At necropsy, animals were examined for gross pathological changes. The animals did not show abnormalities during the first two hours of exposure. During the second two hours of exposure all animals showed breathing at a decreased rate. No clinical abnormalities were observed shortly after exposure or during the remainder of the observation period. Body weight gain was as expected for animals of this age and strain.No treatment-related macroscopic abnormalities were found at necropsy. Mortality did not occur. It is therefore concluded that the 4-hour LC50 is above 5.47 g/m3 for male and female rats.
Dermal route
In accordance with column 2 of REACH Annex VIII-X, as acute toxicity studies for the oral and inhalation route are available, no study regarding the dermal route is needed.
Justification for classification or non-classification
Based on the oral LD50 value of 1337 mg/kg bw, the substance has to be classified according to Directive 67/48/EEC as Xn – R22 (Harmful if swallowed). In accordance to EU Classification, Labeling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, the substance has to be classified for Acute toxicity, Cat. 4 - H302 (Harmful if swallowed). No classification for acute inhalation toxicity is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
